Skip to main content

Publisher: Elsevier

Volume 6, Number 3, 1 February 2001

Implementing new technology: leveraging success
pp. 111-112(2)
Author: Rowe, R.C.

Favourites:
ADD

Nervous system: the next generation
pp. 112-113(2)
Author: Hart, T.

Favourites:
ADD
Favourites:
ADD

A BLySful end to autoimmune disease?
pp. 116-117(2)
Author: Dorrell, S.

Favourites:
ADD

Targeting 'good' cholesterol to treat heart disease
pp. 117-118(2)
Author: Hillery, A.

Favourites:
ADD

The brain: getting ready to work
pp. 119-120(2)
Author: Fricker, J.

Favourites:
ADD

News in brief
pp. 121-124(4)
Authors: Owens, J.; Ramster, B.; Lawrence, R.N.

Favourites:
ADD

People
pp. 124-124(1)
Author: Lawrence, R.N.

Favourites:
ADD

Gene targeting technology and gene therapy of the brain
pp. 125-126(2)
Author: Pardridge, W.

Favourites:
ADD

Oral drug absorption studies: the best model for man is man!
pp. 127-130(4)
Authors: Davis, S.S.; Wilding, I.R.

Favourites:
ADD

Genomics for business
pp. 131-132(2)
Author: Jain, K.K.

Favourites:
ADD

Library design for NMR-based screening
pp. 133-140(8)
Author: Lepre, C.A.

Favourites:
ADD

Using model-system genetics for drug-based target discovery
pp. 141-149(9)
Authors: Matthews, D.J.; Kopczynski, J.

Favourites:
ADD

Monitor: molecules and profiles
pp. 157-159(3)
Author: Barrett, D.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Combinatorial chemistry
pp. 160-160(1)
Author: Edwards, P.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more